Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease.
Kinoshita Y, Ashida K, Hongo M; Japan Rabeprazole Study Group for NERD. Kinoshita Y, et al. Among authors: ashida k. Aliment Pharmacol Ther. 2011 Jan;33(2):213-24. doi: 10.1111/j.1365-2036.2010.04508.x. Epub 2010 Nov 14. Aliment Pharmacol Ther. 2011. PMID: 21083596 Free article. Clinical Trial.
Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.
Ashida K, Kinoshita Y, Hongo M; Japan Rabeprazole Study Group for NERD. Ashida K, et al. Dig Dis Sci. 2011 Aug;56(8):2333-42. doi: 10.1007/s10620-011-1583-4. Epub 2011 Feb 8. Dig Dis Sci. 2011. PMID: 21302138 Clinical Trial.
The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan.
Kinoshita Y, Kobayashi T, Kato M, Asahina K, Haruma K, Shimatani T, Inoue S, Kabemura T, Kurosawa S, Kuwayama H, Ashida K, Hirayama M, Kiyama S, Yamamoto M, Suzuki J, Suzuki H, Matsumoto K, Aoshima M. Kinoshita Y, et al. Among authors: ashida k. J Gastroenterol. 2006 Jun;41(6):554-61. doi: 10.1007/s00535-006-1804-3. J Gastroenterol. 2006. PMID: 16868803 Clinical Trial.
Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito.
Sakata Y, Tominaga K, Kato M, Takeda H, Shimoyama Y, Takeuchi T, Iwakiri R, Furuta K, Sakurai K, Odaka T, Kusunoki H, Nagahara A, Iwakiri K, Furuta T, Murakami K, Miwa H, Kinoshita Y, Haruma K, Takahashi S, Watanabe S, Higuchi K, Fujimoto K, Kusano M, Arakawa T; G-PRIDE study group. Sakata Y, et al. BMC Gastroenterol. 2014 Jul 2;14:116. doi: 10.1186/1471-230X-14-116. BMC Gastroenterol. 2014. PMID: 24990161 Free PMC article. Clinical Trial.
Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.
Kinoshita Y, Sakurai Y, Shiino M, Kudou K, Nishimura A, Miyagi T, Iwakiri K, Umegaki E, Ashida K. Kinoshita Y, et al. Among authors: ashida k. Curr Ther Res Clin Exp. 2016 Dec 21;81-82:1-7. doi: 10.1016/j.curtheres.2016.12.001. eCollection 2016. Curr Ther Res Clin Exp. 2016. PMID: 28119763 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 31688064
440 results